Advertisement

Ads Placeholder
Loading...

Alpha Teknova, Inc.

TKNONASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.16
$0.23(7.85%)
U.S. Market opens in 0h 27m

Alpha Teknova, Inc. (TKNO) Stock Overview

Explore Alpha Teknova, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap169.3M
P/E Ratio-9.80
EPS (TTM)$-0.32
ROE-0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$2.59
3 Months$0.00
1 Year Target$1.51

TKNO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alpha Teknova, Inc. (TKNO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.80 and a market capitalization of 169.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.85%
5-Day Change
13.67%
1-Month Change
35.04%
3-Month Change
-18.97%
6-Month Change
-43.97%
Year-to-Date (YTD) Change
-18.97%
1-Year Change
-35.11%
3-Year Change
9.34%
5-Year Change
-87.36%
All-Time (Max) Change
-87.36%

Contact Information

831 637 1100
2290 Bert Drive, Hollister, CA, 95023

Company Facts

1,730 Employees
IPO DateJun 25, 2021
CountryUS
Actively Trading

Frequently Asked Questions